-
Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases
11 Mar 2024 11:00 GMT
… months, if untreated. About Rhenium (186Re) obisbemeda
Rhenium (186Re) obisbemeda is … trials; possible negative effects of rhenium (186Re) obisbemeda; the continued … evaluation of rhenium (186Re) obisbemeda including through …
-
Stamper taps into significant copper, molybdenum and rhenium mineralization at Redonda
13 Feb 2024 17:59 GMT
… into significant copper, molybdenum and rhenium mineralization within previously unrecognized breccia … .
The recent identification of rhenium adds to the potential for … intersections of copper, molybdenum and rhenium mineralization.
Significantly, each of …
-
Cipher Neutron’s Research Division Receives Funding from Molymet, to Accelerate the Development of Rhenium-Based AEM Electrolysers
23 Jan 2024 11:37 GMT
… s demand for Rhenium.
The largest Rhenium reserves in … AEM Leadership by Commercialising Rhenium
Rhenium use in Cipher … in AEM Electrolysers. Rhenium exhibits excellent catalytic activity … Cipher Neutron, integrating Rhenium into AEM electrolysers, …
-
Cipher Neutron's Research Division Receives Funding from Molymet, to Accelerate the Development of Rhenium-Based AEM Electrolysers
23 Jan 2024 11:07 GMT
… s demand for Rhenium.
The largest Rhenium reserves in the … AEM Leadership by Commercialising Rhenium
Rhenium use in Cipher … in AEM Electrolysers. Rhenium exhibits excellent catalytic activity … Cipher Neutron, integrating Rhenium into AEM electrolysers, …
-
Study helps deploy pioneering method using rhenium as proxy for carbon
14 Nov 2023 14:21 GMT
… PNAS, the researchers substituted rhenium, a heavy transition metal … on a trace element [?] rhenium [?] that's incorporated … atmosphere. As this happens, rhenium is left behind, which … chemical or biological processes, rhenium is relatively inert, making …
-
Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases
03 Nov 2023 11:00 GMT
… ODD, the FDA previously granted rhenium (186Re) obisbemeda Fast Track designation … months, if untreated. About Rhenium (186Re) obisbemeda Rhenium (186Re) obisbemeda is a … manner to optimize patient outcomes. Rhenium (186Re) obisbemeda has the potential …
-
Superatomic material is fastest-ever semiconductor Technology News | October 31, 2023 The fastest semiconductor yet discovered is a superatomic material based on rhenium. Carrier transport in the material is about twice…
31 Oct 2023 11:15 GMT
… extreme rarity and expense of rhenium.
The research team is now …
-
Rhenium (186Re) obisbemeda by Plus Therapeutics for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
28 Oct 2023 07:19 GMT
… likelihood of approval.
Rhenium (186Re) obisbemeda overview
Rhenium (186Re) obisbemeda is … '-diethylethylenediamine (BMEDA)-chelated rhenium nanoliposomes and developed based on … formulation of doxorubicin; BMEDA-chelated rhenium nanoliposome (RNL); and a …
-
Rhenium (186Re) obisbemeda by Plus Therapeutics for Head And Neck Cancer: Likelihood of Approval
28 Oct 2023 07:19 GMT
… likelihood of approval.
Rhenium (186Re) obisbemeda overview
Rhenium (186Re) obisbemeda is … '-diethylethylenediamine (BMEDA)-chelated rhenium nanoliposomes and developed based on … formulation of doxorubicin; BMEDA-chelated rhenium nanoliposome (RNL); and a …
-
MiRus Announces FDA 510(k) Clearance for Molybdenum-Rhenium (MoRe®) Low Profile Anterior Cervical and Lateral Lumbar Plating Systems
18 Oct 2023 15:45 GMT
… market.
MoRe®, a proprietary molybdenum rhenium superalloy for medical implants, provides … for patients.
The proprietary molybdenum-rhenium alloy used in the Integrated …